Allergic Rhinitis Flashcards

1
Q

Allergic Rhinitis

A

Inflammatory disorder of the upper airway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Allergic Rhinitis symptoms

A
– Sneezing
– Rhinorrhea
– Pruritus
– Nasal congestion
– For some people: Conjunctivitis, sinusitis, and
asthma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Seasonal

A

pollen - grass, tree, ragweed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

perennial

A

dust mites, cat and dog dander

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

allergic rhinitis

A

Allergens bind to immunoglobulin E (IgE)

on mast cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Triggers release of inflammatory mediator

A

– Histamine, leukotrienes, prostaglandins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Three pollen seasons

in Minnesota

A

Tree
Grass
Weed
Ragweed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tree

A

early
April until the end of
May.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Grass

A

– early

June to mid-July

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Weed

A

– midJune until a hard frost

occurs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ragweed

A

early August through

mid-October

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Classes of Drugs Used for

Allergic Rhinitis

A
  • Glucocorticoids (intranasal)
  • Antihistamines (oral and intranasal)
  • Sympathomimetics (oral and intranasal)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Intranasal Glucocorticoids are the first

A

choice—most effective for treatment and

prevention of rhinitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Intranasal Glucocorticoids exampoles

A

Budesonide [Rhinocort Aqua], fluticasone
propionate [Flonase], triamcinolone [Nasacort
Allergy}

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Intranasal Glucocorticoids adverse effects

A
– Drying of nasal mucosa or sore throat
– Epistaxis (nosebleed)
– Headache
– Rarely, systemic effects (adrenal suppression and slowing
of linear pediatric growth)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Intranasal Glucocorticoids preferred treatment choice in

A

in pregnancy for moderate
to severe AR, use lowest effective dose (typically
choose budesonide – pregnancy category B)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Oral Antihistamines are

A

H1 receptor antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

H1 are 1st line for

A

• 1st line – mild to moderate AR

19
Q

H1 do not reduce

A

Do not reduce nasal congestion

20
Q

H1 are most effective

A

• Most effective if taken prophylactically

21
Q

H1 should be taken

A

regularly throughout the allergy season, even
when symptoms are absent, to prevent an initial histamine
receptor activation

22
Q

Antihistimine types

A

• 1st and 2nd/3rd generation

23
Q

– 2nd and 3rd generation – less

A

tendency to cause sedation

preferred fewer CNS effects

24
Q

• Mild adverse effects: Sedation with

A
first generation (much less
with second generation)
25
Q

• Anti-cholinergic effects – drying of nasal secretions, dry mouth,
constipation, urinary hesitancy – common with

A

1st generation,

rare with 2nd-generation

26
Q

Intranasal Anti-histamines

examples

A

Azelastine and Olopatadine

27
Q

Intranasal Anti-histamines

indicated for

A

Indicated for allergic rhinitis in adults and in

children over 12 years old

28
Q

Intranasal Anti-histamines

systemic absorption can be

A

can be sufficient to

cause somnolence

29
Q

Intranasal Anti-histamines

SE

A

Nosebleeds, headaches

• Unpleasant taste

30
Q

Intranasal Anti-histamines

combination

A

corticosteroid/anti-histamine

sprays

31
Q

Intranasal Anti-histamines have

A

rapid onset. 15 min

32
Q

Intranasal Cromolyn Sodium is

A

Mast cell stabilizer

33
Q

Intranasal Cromolyn Sodium reduces

A

Reduces symptoms by suppressing the
release of histamine and other inflammatory
mediators from mast cells

34
Q

Intranasal Cromolyn Sodium is used as

A

Prophylaxis

35
Q

Intranasal Cromolyn Sodium administer before

A

Administer before symptoms start

36
Q

Intranasal Cromolyn Sodium response develops in

A

develops in 1 to 2 weeks

37
Q

Intranasal Cromolyn Sodium minimal

A

adverse reactions: Less than with

any other drug for allergic rhinitis

38
Q

Other drugs that can be used for allergic rhinitis

A
• Anti-leukotriene agents
• Ipratropium bromide
• Short courses of oral glucocorticoids
usually abolish symptoms of allergic
rhinitis and may be indicated for severe
allergic rhinitis symptoms that are
preventing the patient from sleeping or
going to work.
• Nasal saline irrigation
39
Q

animal dander avoidence

A

– remove from house. Or keep animal
out of patient’s bedroom. HEPA room air filter. Seal or
put filter on air ducts that leave to the individual’s
bedroom.

40
Q

house mites avoidance

A

encase pillows and mattresses in a DM
cover, was bedding in hot water weekly (>130 degrees).
Remove carpet from bedrooms.

41
Q

cockroaches avoidance

A

– professional extermination, vacuum and
wet wash home, use poison bait o r traps, no food or
garage exposed, repair plumbing leaks, cracks, crevices.

42
Q

indoor mold avoidence

A

– reduce indoor humidity to 50%, are
condition, fix all leaks and eliminate water sources, clean
moldy surfaces.

43
Q

Refer

A

• Children with moderate-to-severe allergic rhinitis.
• Prolonged or severe symptoms of rhinitis or significant residual
symptoms despite pharmacologic therapy and avoidance measures.
• Patients whose management might be enhanced by identification of
allergic triggers.
• Patients with coexisting asthma or nasal polyposis
• Patients with significant complications of allergic rhinitis, such as
recurrent otitis media or recurrent sinusitis.
• Patients with intolerable adverse effects from medications or side
effects that interfere with school/work productivity.
• Patients who are interested in immunotherapy as a treatment option.
• Patients who have required systemic glucocorticoids to control
symptoms